400mcg Sublingual Misoprostol as First Line Treatment

Status Completed

Clinical Trial Summary

Women presenting with incomplete abortion and eligible for treatment with misoprostol were offered 400mcg sublingual misoprostol for treatment. Based on existing literature, the study hypothesises that women can successfully be treated with misoprostol alone as first line treatment.

Clinical Trial Description

n/a

Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01939457
Study type	Interventional
Source	Gynuity Health Projects
Contact
Status	Completed
Phase	N/A
Start date	September 2011
Completion date	August 2012

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05342467` - Gemeprost Versus Dinoprostone in First Trimester Miscarriages	Phase 2
Completed	`NCT00674232` - Treatment of Incomplete Abortion With 600 Mcg Oral Misoprostol Compared to Standard Surgical Treatment	N/A
Completed	`NCT02707653` - Sublingual Misoprostol for the Treatment of Incomplete Abortion: Operations Research	N/A
Not yet recruiting	`NCT05343546` - Ideal Timing of Intrauterine Contraception Insertion After Medical Management of First Trimester Incomplete Abortion	N/A
Recruiting	`NCT01775917` - The Role of Uterine Artery Doppler Parameters in the Management of Retained Products of Conception.	N/A
Completed	`NCT00466999` - Sublingual Misoprostol Versus Standard Surgical Care for the Treatment of Incomplete Abortion	N/A
Completed	`NCT01539408` - Sublingual Misoprostol Versus Standard Surgical Care for the Treatment of Incomplete Abortion in Nigeria	Phase 1
Completed	`NCT03622073` - Misoprostol Treatment of Mid Trimester Incomplete Abortion by Midwives and Doctors in Uganda.	N/A
Completed	`NCT01743508` - Misoprostol Treatment of Incomplete Abortion by Midwives and Physicians in Uganda	N/A